E

Evommune Inc.
D

EVMN

26.550
USD
1.35
(5.36%)
مغلق
حجم التداول
18,829
الربح لكل سهم
-2
العائد الربحي
-
P/E
-13
حجم السوق
836,964,669
المقالات

العنوان: Evommune Inc.

القطاع: Healthcare
الصناعة: Biotechnology
Evommune Inc is a clinical-stage biotechnology company focused on creating new therapies aimed at key factors driving chronic inflammatory diseases. The initial clinical programs of the company target chronic spontaneous urticaria (CSU), atopic dermatitis (AD), and ulcerative colitis (UC). The pipeline products of the company include EVO756 and EVO301.